Financial Impact of Health Care–Associated Infections

Abstract This chapter examines the financial impact of health care–associated infections (HAIs) in the United States, estimating their annual cost at $10 billion. The underlying study focused on the financial burden of five major HAIs: central line–associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections, ventilator-associated pneumonia, surgical site infections (SSIs), and methicillin-resistant Staphylococcus aureus. The study combined data from 26 research articles and the National Healthcare Safety Network, estimating the incidence and costs associated with each infection. The study found that SSIs and Clostridium (now Clostridioides) difficile infections are the most frequent, with CLABSIs being the most expensive per case. Finally, the chapter highlights the financial implications of HAIs, urging health care administrators to prioritize prevention strategies.